Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients

Arthritis and Rheumatism

Volumn 43, Issue 9, 2000, Pages 1976-1981

  Lauwerys, Bernard R ^a   Garot, Nathalie ^a   Renauld, Jean Christophe ^b   Houssiau, Frédéric A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ALLOGENEIC RESTRICTION; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL DIVISION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0033695248     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200009)43:9<1976::AID-ANR8>3.0.CO;2-V     Document Type: Article

References (20)

1. Systemic autoimmune disease arises from polyclonal B cell activation
2. Immune function in systemic lupus erythematosus: Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen
3. Impaired cell-mediated immunity in systemic lupus erythematosus (SLE): A controlled study of 23 untreated patients
4. Defective antigen-presenting cell function in patients with systemic lupus erythematosus: Role of the B7-1 (CD80) costimulatory molecule
5. Causes of death in systemic lupus erythematosus: Long-term followup of an inception cohort
6. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus
7. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus
8. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
9. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
10. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells
11. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10
12. Induction of Th2 cell differentiation in the primary immune response: Dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4
13. Effect of interleukin-10 on dendritic cell maturation and function
14. The 1982 revised criteria for the classification of systemic lupus erythematosus
15. Derivation of the SLEDAI: A disease activity index for lupus patients
16. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus
17. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 monocytes
18. Impaired production of IL-12 in systemic lupus erythematosus. II. IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE
19. Impaired production of IL-12 in systemic lupus erythematosus. III. Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression
20. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells